GTCR is in talks with direct lenders, including KKR, to raise financing for a potential acquisition of Prague-based drugmaker Zentiva, according to Bloomberg. The deal could value the business at about €5bn ($5.8bn), according to a report by Bloomberg. Sources said discussions are ongoing and there is no certainty a transaction will materialise. Other firms previously linked to a potential bid include TPG and Aurobindo Pharma of India. Advent bought Zentiva from Sanofi in 2018 for €1.9bn and has hired Goldman Sachs and PJT Partners to advise on the sale process.
Read the full article: GTCR Explores Private Debt Financing for Potential $5.8B Zentiva Acquisition //
Source: https://pe-insights.com/gtcr-explores-private-debt-financing-for-potential-5-8bn-zentiva-acquisition/